DIMERIX LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.49 AUD | -1.01% |
|
+25.64% | +139.02% |
| 05-29 | Euroz Hartleys Adjusts Dimerix’s Price Target to AU$0.86 From AU$0.80, Keeps at Speculative Buy | MT |
| 05-27 | Dimerix Signs License Deal for Kidney Disease Medication in the Middle East | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 181M | - | - | - | - | - | |
| 55.7B | - | |||||
| 39.91B | ||||||
| 39.57B | ||||||
| 28.16B | ||||||
| 26.3B |
- Stock Market
- Equities
- DXB Stock
- Charts Dimerix Limited
- Sector Chart
